Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 2 | Ria Pharmaceuticals And SurgicalsLikely | 1 | ₹8.1 L |
| 2 | Schedule 3 | NEXGEN ENTERPRISESLikely | 1 | ₹10.2 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
11 Nov 2025, 1:00 pmClosed
US FDA approved cobalt chromium or platinum chromium zotarilimus eluting 4th generation coronary ste
everolimus eluting platinum chromium stent on dual layer balloon assorted sizes
sirolimus drug eluting cobalt chromium biodegradable polymer coated with hybrid open cell
double he
8470728
GEM/2025/B/6787871
Two Packet Bid
US FDA approved cobalt chromium or platinum chromium
30 days
Jammu And Kashmir; Udhampur
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹12 L
₹36 L
30%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| US FDA approved cobalt chromium or platinum chromium zotarilimus eluting 4th generation coronary ste | - | - | - |
| everolimus eluting platinum chromium stent on dual layer balloon assorted sizes | - | - | - |
| sirolimus drug eluting cobalt chromium biodegradable polymer coated with hybrid open cell | - | - | - |
| double he | - | - | - |
Exempted
11 Nov 2025
25 Oct 2025
11 Nov 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8470728.pdf
GEM_BID
u1_2025-10-14-10-08-32_13821db7605f396f77063fd99534fdc8.pdf
SPECIFICATION
u2_2025-10-14-12-32-50_aedfca41637ab38d3e80796b3c2c6bd1.pdf
SPECIFICATION
u3_2025-10-14-12-33-46_2d3270daf40ff8f380ac7d2bedce2202.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .